OncoMark

OncoMark has developed a novel prognostic test for breast cancer that identifies those patients who do not require chemotherapy, a market worth €1.1BN.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Dublin, Ireland
  • Currency EUR
  • Founded January 2007
  • Employees 8
  • Website oncomark.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free